Verici Dx PLC Ordinary Shares (VRCI)

Industry Diagnostics & Research

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.75p

Buy

0.80p

arrow-down-0.05p (-5.88%)

Prices updated at 16 Dec 2025, 16:38 GMT

Prices minimum 15 mins delay

Prices in GBX

FTSE All-Share

-0.61%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Mr. Julian Huw Baines MBE

CEO

Ms. Sara Jane Barrington

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

15

Head office

19 Stanwell Road

Cardiff

United Kingdom

CF64 2EZ

+44 2920710570

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Sir Ian James Carruthers OBE Non-Executive Director, Senior Independent Non-Executive Director	-
Mr. Julian Huw Baines MBE Non-Executive Director, Chairman	-
Mr. James Renwick McCullough Non-Executive Director	-
Dr. Lorenzo Giovanni Gallon Non-Executive Director	-
Ms. Sara Jane Barrington Executive Director, Chief Executive Officer	-
Mr. David Anderson Company Secretary	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Unicorn Asset Management Ltd	119,619,325
Unicorn AIM VCT Series 3 ORD	119,619,325
Crux Asset Management Limited	44,000,000
TM Oberon UK Smaller Companies Fund	44,000,000
Ruffer LLP	40,000,000

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.